Iterum Therapeutics plc (ITRMF) Net Margin (2017 - 2025)

Iterum Therapeutics has reported Net Margin for 4 years, with the latest figure at 2302.31% in Q3 2025.

• On a quarterly basis, Net Margin changed N/A year-over-year to 2302.31% in Q3 2025; TTM through Sep 2025 was 6913.08%, a N/A change from a year earlier, with the FY2019 full-year figure at 278729.73%, down 26986253.0% from the prior year.
• Net Margin was 2302.31% for Q3 2025 at Iterum Therapeutics, up from 55621.62% in the prior quarter.
• The five-year high for Net Margin was 2302.31% in Q3 2025, with the low at 2302.31% in Q3 2025.